| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/15/2004 | US20040073969 Cyclin-dependent kinase inhibitors and uses thereof |
| 04/15/2004 | US20040073968 Stably transformed plant for use in expression of heterologous proteins; waste water treatment; bioreactors; bioremediation |
| 04/15/2004 | US20040073967 Directing insertion of expression vector into subtelomeric region of chromosomes; homologous recombination genetic engineering |
| 04/15/2004 | US20040073966 Preparing and propagating transgenic isoxafutole resistant maize; enzyme inhibitors |
| 04/15/2004 | US20040073965 Regulatory element from a sugarcane proline rich protein and used thereof |
| 04/15/2004 | US20040073963 Transgenic mammals |
| 04/15/2004 | US20040073962 Animal model for perimenopause and menopause and methods of inducing ovarian failure |
| 04/15/2004 | US20040073960 Model animals for visualization of neutral pathways |
| 04/15/2004 | US20040073959 Genetic control of sex ratio in animal populations |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073957 Isolation of a rearranged human immunoglobulin gene from a chimeric mouse and recombinant production of the encoded immunoglobulin |
| 04/15/2004 | US20040073956 Assay techniques based on growth stage dependent expression inc. elegans |
| 04/15/2004 | US20040073955 Genetically engineered flies for identifying and treating neuroegenerative diseases |
| 04/15/2004 | US20040073022 Tobacco enhancer sequences identified using promoterless glucuronidase vector; genetic engineering and gene expression |
| 04/15/2004 | US20040073017 Surface modification, linker attachment, and polymerization methods |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040073005 Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation |
| 04/15/2004 | US20040073004 Comprises Ajuba like protein for diagnosis, prevention and treatment of cell proliferative, cardiovascular and neurodegenerative disease |
| 04/15/2004 | US20040073003 Neuromedin u delta |
| 04/15/2004 | US20040073002 Method for mass-production of target protein by regulating the expression of chaperone protein |
| 04/15/2004 | US20040073001 Beta-catenin nuclear localized protein |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072999 Novel protein inhibitor of apoptosis proteins |
| 04/15/2004 | US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072805 Use of tumor necrosis factor inhibitors to treat cardiovascular disease |
| 04/15/2004 | US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents |
| 04/15/2004 | US20040072787 Cancer |
| 04/15/2004 | US20040072783 DNA catalysts, DNA enzymes; to target virtually any RNA transcript; for cleavage of RNA or DNA; do not share sequence homology with other known DNA enzymes |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072778 Prognosis of neuroblastoma; antisense nucleic acids for malignant tumors |
| 04/15/2004 | US20040072777 Nucleic acid sequence to treat infections of the epididymis |
| 04/15/2004 | US20040072776 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 04/15/2004 | US20040072774 Methods for expressing and targeting mitochondrial-DNA-encoded peptides and uses thereof |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072771 Ex vivo gene therapy; HIV infection; at least 1.63 x 106 CD34+ hematopoietic cells (per kg of body weight) being transduced with a viral construct which expresses an anti-HIV agent |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | US20040072768 Screening for the ability of a putative compound to inhibit induction of Egr-1, decrease expression of Egr-1 or decrease the nuclear accumulation or activity of the Egr-1 gene product; antisense oligonucleotides |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072752 Providing the amelioration of symptoms, caused by gene overexpression of encoding a cytokine suppressor; treating rheumatoid arthritis |
| 04/15/2004 | US20040072751 A kits for use in drug screening antagonists, agonists; a recombinant vector polynucleotide, cell culturing, an antibody used for diagnostic, for adjusting the expression of the G protein-coupled receptor protein |
| 04/15/2004 | US20040072747 Novel member of the epha receptor family |
| 04/15/2004 | US20040072743 Pharmaceutical composition of modified pna molecules |
| 04/15/2004 | US20040072742 Novel gene and use thereof |
| 04/15/2004 | US20040072740 Directed evolution of enzymes and antibodies |
| 04/15/2004 | US20040072739 Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes |
| 04/15/2004 | US20040072738 Analogues of thiocoraline and be-22179 |
| 04/15/2004 | US20040072726 Decoy is an NF- kappa B decoy, an ets decoy, or a chimera decoy of NF- kappa B and ets. The disease is cerebral aneurysm, cancer, aortic detachment, post-angioplasty restenosis, chronic articular rheumatism, asthma, atopic etc. |
| 04/15/2004 | US20040072354 Trangenic microorganism for expression of heterologous proteins; bioreactors and fermentation |
| 04/15/2004 | US20040072353 Generation and propagation of transgenic korean grass plant comprising enhanced flowering, branching and leaf growth; resistance to biotic and abiotic stresses |
| 04/15/2004 | US20040072352 Plasmid which provides position independent expression of foreign proteins and enhanced gene expression; genetic engineering and position effect inhibition |
| 04/15/2004 | US20040072351 Generating transgenic antigen presenting cells using adeno-associated viral vector and associated proteins; gene therapy and treatment of tumors, graft rejection and autoimmune diseases |
| 04/15/2004 | US20040072344 Differentiating pluripotent stem cells into pancreatic or nervous system tissues for treatment of nervous system and pancreatic disorders; transplant therapy; tissue engineering |
| 04/15/2004 | US20040072328 Plasmid shuttle vector between eschelichia coli and bacteria of genus brevibacillus |
| 04/15/2004 | US20040072326 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 04/15/2004 | US20040072325 Preparing transgenic filamentous fungi comprising regulatory tools for monitoring transcriptional regulation |
| 04/15/2004 | US20040072324 Controlling bacteria infections; complex of carbohydrate and acetylgalactosaminidase; hybrid protein; genetic engineering |
| 04/15/2004 | US20040072318 Novel protein-deamidating enzyme, gene encoding the same, production process therefor , and use thereof |
| 04/15/2004 | US20040072317 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses |
| 04/15/2004 | US20040072316 Production of weakly active or inactive mutants of alkaline phosphatase and their expression in yeast |
| 04/15/2004 | US20040072312 Process for producing ethanol by using recombinant coryneform bacterium |
| 04/15/2004 | US20040072307 Processes for enhanced production of pantothenate |
| 04/15/2004 | US20040072305 Preparing CDNA sequences from RNA sequences extracted from formalin-fixed and optionally paraffin-embedded (FFPE) cells for diagnosing breast cancer |
| 04/15/2004 | US20040072304 Preparing dealkylated nucleotide sequences and diagnosing autoimmune and inflammatory sequences |
| 04/15/2004 | US20040072300 Comprises expression vector coding cytokines/immunoglobulin fusion protein for treating tumor and autoimmune disorders; immunotherapy; antitumor agents |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040072293 Comprise genetically engineered peptides for treatment and prevention of gastrointestinal disorders; mimetics |
| 04/15/2004 | US20040072292 Comprises nucleotide sequences coding goose-type lysozyme (LYG2) for diagnosis, treatment and prevention of autoimmune, inflammatory, renal, adrenal and cancer disorders |
| 04/15/2004 | US20040072291 Comprises genetically engineered nerve growth factor for diagnosis and treatment of nervous system and neurodegenerative disease |
| 04/15/2004 | US20040072290 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 04/15/2004 | US20040072289 Comprises nucleotide sequences coding transcriptional regulatory protein for generation and propagation drought, freeze and salt resistant plants; tissue engineering |
| 04/15/2004 | US20040072286 Comprises nucleotide sequences coding synovium/cartilage inflammation-linked messenger 1 (SCIM-1) for diagnosis and treatment of rhematoid arthritis |
| 04/15/2004 | US20040072285 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 04/15/2004 | US20040072283 Rapid immunoselection cloning method |
| 04/15/2004 | US20040072276 Preparing enzymatic polypeptide with target substrate specificities for use in medical diagnostics, textile treatment and papermaking |
| 04/15/2004 | US20040072271 Using recombinantly derived antibodies (rVab) to identify unique active surfaces of pharmaceutical targets |
| 04/15/2004 | US20040072265 Using tumor antigen CDNA probes to diagnose and treat brain disorders; antiproliferative/antitumor agents |
| 04/15/2004 | US20040072264 Comprises nucleotide sequences coding ca protein (CAP) for diagnosing and treating cell proliferative disorders; antiproliferative agents |
| 04/15/2004 | US20040072258 Disruption of a Ras-protein complex by a Ras antagonist, e.g.,farensylthiosalicylic acid, analyzed; identifying drug candidates inhibiting aberrant Ras activity; binding andinactivating mRNA of anchor protein by a oligonucleotides |
| 04/15/2004 | US20040072256 Nk cells activiating receptors and their therapeutic and diagnostic uses |
| 04/15/2004 | US20040072253 Novel protein and DNA thereof |
| 04/15/2004 | US20040072245 Methods, systems, and software for identifying functional biomolecules |
| 04/15/2004 | US20040072243 Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 04/15/2004 | US20040072242 Determining total microbial content in sample via amplification of ribosomal DNA; bioremediation; biodegradation; diagnosing bacterial infections |
| 04/15/2004 | US20040072239 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 04/15/2004 | US20040072238 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 04/15/2004 | US20040072234 High affinity nucleic acid ligands to lectins |
| 04/15/2004 | US20040072233 Multihue labels |
| 04/15/2004 | US20040072229 Comprises nucleotide sequences coding ligand binding membrane protein for identifying modulator for treatment of kidney, neural, pancreatic or prostate diseases |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072219 Genetically engineered obesity protein with reduced immune response for treatment of diabetes, high blood pressure and cholesterol metabolism disorders |
| 04/15/2004 | US20040072218 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 04/15/2004 | US20040072215 Solid-phase nucleic acid isolation |
| 04/15/2004 | US20040072213 Compositions for DNA amplification, synthesis, and mutagenesis |